Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

Discontinuation of mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team

Judith Silverstein Currier, Paige L. Williams, Susan L. Koletar, Susan Ellen Cohn, Robert L. Murphy, Alison Heald, Richard Hafner, Ehab Bassily, Howard M. Lederman, Charles Knirsch, Constance A. Benson, Hernan Valdez, Judith A. Aberg, J. Allen McCutchan. Discontinuation of mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. Annals of Internal Medicine. 2000. 133: 493-503.

Year

2000

Journal

Annals of Internal Medicine

Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors

Mark A. Winters, Kristi L. Coolley, Peng Cheng, Yvette A. Girard, Hasnah Hamdan, Ladislau C. Kovari, Thomas C. Merigan. Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors. Journal of Virology. 2000. 74: 10707-13.

Year

2000

Journal

Journal of Virology

Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests

J. Robins, Dianne M. Finkelstein. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000. 56: 779-88.

Year

2000

Journal

Biometrics

Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks

Charles Raines, Charles Flexner, Eugene Sun, Margo E. Heath-Chiozzi, Ronald Lewis, Catherine Fields, C. Deetz, Linda Apuzzo, Susan H. Eshleman, Brooks Jackson, Joel E. Gallant. Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks. Journal of Acquired Immune Deficiency Syndromes. 2000. 25: 322-8.

Year

2000

Journal

Journal of Acquired Immune Deficiency Syndromes

Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children

Leock Y. Ngo, Ram Yogev, Wayne M. Dankner, Walter T. Hughes, Sandra Burchett, Jing Xu, Brian Sadler, Jashvant D. Unadkat. Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 1999. 43: 1516-19.

Year

1999

Journal

Antimicrobial Agents and Chemotherapy

Combination Therapy with Stavudine (d4T) Plus Didanosine (ddI) In Children With Human Immunodeficiency Virus Infection

Mark W. Kline, Russell B. Van Dyke, Jane C. Lindsey, Meg Gwynne, Mary Culnane, Clemente Diaz, Ram Yogev, Ross E. McKinney, Elaine J. Abrams, Lynne M. Mofenson. Combination Therapy with Stavudine (d4T) Plus Didanosine (ddI) In Children With Human Immunodeficiency Virus Infection. Pediatrics. 1999. 103: e62.

Year

1999

Journal

Pediatrics

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211)

William T. Shearer, Mark W. Kline, Stuart L. Abramson, Terence Fenton, Stuart E. Starr, Steven D. Douglas. Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211). Clinical and Diagnostic Laboratory Immunology. 1999. 6: 311-15.

Year

1999

Journal

Clinical and Diagnostic Laboratory Immunology

Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children

Stevens RC, Frenkel LM, Rodman JH. Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children. Pharmacotherapy. 1999. 19: 487.

Year

1999

Journal

Pharmacotherapy

Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter)

Shapiro DE, Sperling RS, Coombs RW. Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter). Lancet. 1999. 354: 156.

Year

1999

Journal

Lancet